
Current Market Outlook
The market had another constructive week, and today, the S&P 500 actually nosed out to new highs, with the Nasdaq close behind. While small- and mid-cap indexes are still further behind, the tenor of the overall market continues to improve—it’s likely not up and away, but the odds continue to favor the next big move being up. Individual stocks remain far trickier, with rotation occurring daily, but our thoughts from last week haven’t changed much: Given the many solid setups out there, a positive earnings season could launch a bunch of new leaders we can hop on (we think we’ve already highlighted some of them), but it’s still up to the bulls to produce a bunch more powerful breakouts in the indexes and individual stocks.
This week’s list is a mix of recent earnings winners and others that are set up nicely ahead of reports this week. Our Top Pick is
Vertex Pharmaceuticals (VRTX), which might finally be getting going after years of ups and downs. Earnings are due Wednesday evening so handle with care.
| Stock Name | Price | Buy Range | Loss Limit |
|---|
| ACADIA Pharmaceuticals (ACAD) | 47.84 | 40-42.5 | 35-36.5 |
| Allegiant Travel (ALGT) | 170.65 | 164-168 | 151-153 |
| Fortune Brands Home & Security (FBHS) | 81.02 | 58-60 | 53.5-54.5 |
| Lam Research (LRCX) | 268.47 | 260-270 | 240-245 |
| Pinduoduo (PDD) | 87.53 | 39.5-41.5 | 35-36 |
| Reliance Steel & Aluminum Co. (RS) | 117.45 | 114-118.5 | 103-105 |
| Seattle Genetics (SGEN) | 150.85 | 99-103 | 89-91 |
| Teladoc, Inc. (TDOC) | 127.95 | 69-72 | 62-63.5 |
| Valero Energy (VLO) | 97.40 | 95-98.5 | 86-88 |
| Vertex Pharmaceuticals (VRTX) | 230.36 | 191-196 | 178-180 |